Academic literature on the topic 'LytM-domain'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Contents
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'LytM-domain.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "LytM-domain"
Uehara, Tsuyoshi, Thuy Dinh, and Thomas G. Bernhardt. "LytM-Domain Factors Are Required for Daughter Cell Separation and Rapid Ampicillin-Induced Lysis in Escherichia coli." Journal of Bacteriology 191, no. 16 (June 12, 2009): 5094–107. http://dx.doi.org/10.1128/jb.00505-09.
Full textAn, Doo Ri, Hyoun Sook Kim, Jieun Kim, Ha Na Im, Hye Jin Yoon, Ji Young Yoon, Jun Young Jang, et al. "Structure of Csd3 fromHelicobacter pylori, a cell shape-determining metallopeptidase." Acta Crystallographica Section D Biological Crystallography 71, no. 3 (February 26, 2015): 675–86. http://dx.doi.org/10.1107/s1399004715000152.
Full textSabala, Izabela, Ing-Marie Jonsson, Andrej Tarkowski, and Matthias Bochtler. "Anti-staphylococcal activities of lysostaphin and LytM catalytic domain." BMC Microbiology 12, no. 1 (2012): 97. http://dx.doi.org/10.1186/1471-2180-12-97.
Full textJagielska, Elzbieta, Olga Chojnacka, and Izabela Sabała. "LytM Fusion with SH3b-Like Domain Expands Its Activity to Physiological Conditions." Microbial Drug Resistance 22, no. 6 (September 2016): 461–69. http://dx.doi.org/10.1089/mdr.2016.0053.
Full textSexton, Danielle L., Francesca A. Herlihey, Ashley S. Brott, David A. Crisante, Evan Shepherdson, Anthony J. Clarke, and Marie A. Elliot. "Roles of LysM and LytM domains in resuscitation-promoting factor (Rpf) activity and Rpf-mediated peptidoglycan cleavage and dormant spore reactivation." Journal of Biological Chemistry 295, no. 27 (May 20, 2020): 9171–82. http://dx.doi.org/10.1074/jbc.ra120.013994.
Full textOsipovitch, Daniel C., and Karl E. Griswold. "Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent." FEMS Microbiology Letters 362, no. 2 (December 8, 2014): 1–7. http://dx.doi.org/10.1093/femsle/fnu035.
Full textMeisner, J., and C. P. Moran. "A LytM Domain Dictates the Localization of Proteins to the Mother Cell-Forespore Interface during Bacterial Endospore Formation." Journal of Bacteriology 193, no. 3 (November 19, 2010): 591–98. http://dx.doi.org/10.1128/jb.01270-10.
Full textPeters, Nick T., Cécile Morlot, Desirée C. Yang, Tsuyoshi Uehara, Thierry Vernet, and Thomas G. Bernhardt. "Structure-function analysis of the LytM domain of EnvC, an activator of cell wall remodelling at theEscherichia colidivision site." Molecular Microbiology 89, no. 4 (July 23, 2013): 690–701. http://dx.doi.org/10.1111/mmi.12304.
Full textCook, Jonathan, Tyler C. Baverstock, Martin B. L. McAndrew, Phillip J. Stansfeld, David I. Roper, and Allister Crow. "Insights into bacterial cell division from a structure of EnvC bound to the FtsX periplasmic domain." Proceedings of the National Academy of Sciences 117, no. 45 (October 23, 2020): 28355–65. http://dx.doi.org/10.1073/pnas.2017134117.
Full textAn, Doo Ri, and Se Won Suh. "Crystal structure of the Csd3 protein from Helicobacter pylori." Acta Crystallographica Section A Foundations and Advances 70, a1 (August 5, 2014): C1630. http://dx.doi.org/10.1107/s2053273314083697.
Full textDissertations / Theses on the topic "LytM-domain"
GURNANI, SERRANO CARLOS KARAN. "ROLE OF PEPTIDOGLYCAN REMODELING IN OVERCOMING LPS BIOGENESIS DEFECTS IN ESCHERICHIA COLI." Doctoral thesis, Università degli Studi di Milano, 2021. http://hdl.handle.net/2434/783882.
Full textShaku, Tube Moagi. "Characterization of LYTM domain containing proteins in mycobacterium smegmatis." Thesis, 2017. http://hdl.handle.net/10539/23164.
Full textMycobacterium tuberculosis assembles a complex cell wall consisting of mycolic acids, arabinogalactan and peptidoglycan layers. The peptidoglycan is important for structural maintenance and osmotic protection of the cell. Beta-lactam antibiotics, such as penicillin, perturb biogenesis of cross-linked peptidoglycan by inhibition of penicillin-binding proteins and cause cell death. As a result, penicillin-binding proteins have been extensively used in antimicrobial development. However, penicillin insensitive enzymes involved in peptidoglycan biogenesis such as amidases, transglycosylases and endopeptidases remain to be exploited for anti-TB drug development, a field that urgently requires new drugs in light of the rapid emergence of drug resistant strains. In this study, we functionally characterize a novel class of LytM domain containing peptidoglycan endopeptidases (also known as M23 peptidases) in mycobacteria. Bio-informatics tools were used to identify LytM domain-containing homologues in Mycobacterium smegmatis, designated MepB1-MepB4. These were deleted using standard allelic exchange mutagenesis and recombination techniques and the resulting mutants were assessed for cell wall related defects. We found that mycobacterial LytM endopeptidases have important roles in bacterial growth as demonstrated by delayed cell growth kinetics in a ΔmepB1 deletion mutant. We noted no growth defects in ΔmepB2 and ΔmepB3 single deletion mutants but observed defective cell division in a ΔmepB2 ΔmepB3 double deletion mutant. In this double mutant, spatial localization of new cell wall biosynthesis revealed the inability to degrade the septal bridge joining two daughter cells, pointing to a critical role for these enzymes in cell separation. MepB1 is sequestered from the peptidoglycan by cytosolic localization and its absence causes a septal and polar buldging phenotype. To further investigate the biological roles of these putative peptidoglycan endopeptidases, protein interaction studies were conducted using the bacterial two-hybrid mycobacterial protein fragment complementation assay. This analysis identified FtsX, a key cell division protein, as an interacting partner for both MepB2 and MepB3, thus identifying these proteins as novel components of the mycobacterial divisome. Collectively, these observations provide the first insight into a new group of potential drug targets for tuberculosis disease and notably enhance the overall understanding of peptidoglycan turnover, which is of general revelevance in bacterial pathogens.
MT2017